Lipoflex Special (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

Lipoflex Special is used to address nutritional deficits in clinical settings where parenteral nutrition is indicated.

• Critical care patients: supports protein synthesis and prevents catabolism in intensive care units.
• Post‑operative recovery: provides essential amino acids to aid wound healing after major surgery.
• Malabsorption syndromes: supplies amino acids when gastrointestinal absorption is insufficient.
• Severe burns patients: replenishes amino acid losses associated with extensive tissue damage.
• Neonatal intensive care: delivers a balanced amino acid profile for premature infants requiring parenteral nutrition.

• Lipoflex Special delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. The amino acids serve as substrates for ribosomal protein synthesis, replenish intracellular pools, and support gluconeogenesis and nitrogen balance. By bypassing the gastrointestinal tract, the formulation ensures rapid availability for metabolic processes in patients unable to ingest or absorb nutrients orally. These amino acids also stimulate insulin secretion, which further promotes anabolic pathways.

Lipoflex Special may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Infusion site erythema: redness or irritation at the injection site.
• Mild hyperammonemia: transient elevation of blood ammonia levels.
• Nausea or vomiting: gastrointestinal discomfort following infusion.
• Headache: mild to moderate cranial pain.
• Fever: low‑grade temperature rise during or after administration.
• Electrolyte imbalance: minor shifts in potassium or calcium levels.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate medical intervention.
• Severe metabolic acidosis: significant pH decline in blood.
• Renal dysfunction: acute kidney injury linked to high amino acid load.
• Hepatic dysfunction: liver enzyme elevation or failure.
• Thrombophlebitis: clot formation in the vein used for infusion.
• Sepsis: bloodstream infection related to catheter use.

When using Lipoflex Special, clinicians should observe several precautionary measures to minimise risk.

• Renal impairment: assess kidney function and adjust infusion rate as needed.
• Hepatic impairment: monitor liver enzymes and ammonia levels during therapy.
• Metabolic disorders: avoid use in patients with inborn errors of amino acid metabolism.
• Electrolyte monitoring: check serum electrolytes regularly to detect imbalances.
• Hypersensitivity: discontinue if signs of allergic reaction appear.
• Aseptic technique: ensure sterile handling of the infusion set to prevent infection.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lipoflex Special can interact with certain medications, influencing safety or efficacy.

Major Interactions (Avoid)

• High‑dose renal toxic drugs: concurrent use may exacerbate kidney injury.
• Hepatotoxic agents: combined effect can increase risk of liver dysfunction.
• Anticoagulants: amino acid solutions may alter coagulation parameters, raising bleeding risk.

Moderate Interactions (Monitor Closely)

• Diuretics: may intensify electrolyte disturbances when combined with amino acid infusion.
• Insulin therapy: amino acids can stimulate insulin release, requiring dose adjustment.
• Other parenteral nutrition components: co‑administration should be coordinated to avoid nutrient excess.